Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
33M
-
Shares change
-
+1.47M
-
Total reported value, excl. options
-
$2.14B
-
Value change
-
+$93.2M
-
Put/Call ratio
-
0.45
-
Number of buys
-
71
-
Number of sells
-
-62
-
Price
-
$64.92
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q4 2015
172 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2015.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33M shares
of 58.6M outstanding shares and own 56.27% of the company stock.
Largest 10 shareholders include FMR LLC (5.65M shares), WELLINGTON MANAGEMENT GROUP LLP (5.27M shares), Capital World Investors (3.14M shares), BB BIOTECH AG (2.16M shares), Flagship Ventures 2007 General Partner LLC (1.93M shares), VANGUARD GROUP INC (1.86M shares), FIRST TRUST ADVISORS LP (1.46M shares), Capital International Investors (1.35M shares), Clearbridge Investments, LLC (1.32M shares), and STATE STREET CORP (903K shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.